BRIEF-Tonix to present data from Phase 2 clinical study of TNX-102 SL

* Will present positive data from Phase 2 dose-finding

clinical study of TNX-102 SL for treatment of military-related

PTSD

Source text for Eikon:

Further company coverage:

(Bengaluru Newsroom: +1-646-223-8780)

Read more